Literature DB >> 1902412

N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma.

R Bernards1.   

Abstract

In neuroblastoma, amplification of the N-myc gene is closely correlated with increased metastatic ability. The mechanism by which N-myc acts to increase neuroblastoma malignancy is poorly understood as yet. It is shown here that transfection of N-myc in a neuroblastoma cell line causes suppression of one isoform of protein kinase C, named delta, and induction of an unusual type of protein kinase C, named zeta. N-myc-transfected neuroblastoma cells were found to be blocked in the activation of both c-fos mRNA and the NF-kappa B transcription factor by phorbol ester. Introduction of a protein kinase C expression vector in N-myc transfected neuroblastoma cells restored inducibility of both c-fos and NF-kappa B by phorbol ester. These observations indicate that changes in protein kinase C gene expression significantly alter the response of N-myc-amplified neuroblastomas to a variety of external signals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902412      PMCID: PMC452765          DOI: 10.1002/j.1460-2075.1991.tb08052.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Transformation by a ras oncogene causes increased expression of protein kinase C-alpha and decreased expression of protein kinase C-epsilon.

Authors:  C Borner; S N Guadagno; L L Hsieh; W L Hsiao; I B Weinstein
Journal:  Cell Growth Differ       Date:  1990-12

Review 2.  Transcriptional regulation by dimerization: two sides to an incestuous relationship.

Authors:  N Jones
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

3.  Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein.

Authors:  L Gandino; M F Di Renzo; S Giordano; F Bussolino; P M Comoglio
Journal:  Oncogene       Date:  1990-05       Impact factor: 9.867

4.  The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

Authors:  D W Ballard; W H Walker; S Doerre; P Sista; J A Molitor; E P Dixon; N J Peffer; M Hannink; W C Greene
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression.

Authors:  P M Choi; K M Tchou-Wong; I B Weinstein
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  N-myc down regulates neural cell adhesion molecule expression in rat neuroblastoma.

Authors:  R Akeson; R Bernards
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate.

Authors:  S Påhlman; L Odelstad; E Larsson; G Grotte; K Nilsson
Journal:  Int J Cancer       Date:  1981-11-15       Impact factor: 7.396

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  17 in total

1.  Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies.

Authors:  T Watanabe; Y Ono; Y Taniyama; K Hazama; K Igarashi; K Ogita; U Kikkawa; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 2.  Protein kinase C isoenzymes: divergence in signal transduction?

Authors:  H Hug; T F Sarre
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

3.  Protein kinase Cdelta mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells.

Authors:  K C Corbit; D A Foster; M R Rosner
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

4.  Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

Authors:  L T Peltenburg; P I Schrier
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

Authors:  L T Peltenburg; R Dee; P I Schrier
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

6.  A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.

Authors:  M Billaud; K J Isselbacher; R Bernards
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Purification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 gene.

Authors:  D A Potter; C J Larson; P Eckes; R M Schmid; G J Nabel; G L Verdine; P A Sharp
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

8.  Structure and expression of major histocompatibility complex-binding protein 2, a 275-kDa zinc finger protein that binds to an enhancer of major histocompatibility complex class I genes.

Authors:  L J van 't Veer; P M Lutz; K J Isselbacher; R Bernards
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Staurosporine differentially inhibits glioma versus non-glioma cell lines.

Authors:  G H Baltuch; N P Dooley; W T Couldwell; V W Yong
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

10.  Novel regulatory factors interacting with the promoter of the gene encoding the mRNA cap binding protein (eIF4E) and their function in growth regulation.

Authors:  K A Johnston; M Polymenis; S Wang; J Branda; E V Schmidt
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.